ResearchStudyPhase

{
  "description" : "Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation.",
  "date" : "2019-11-01T09:29:23+11:00",
  "meta" : {
    "lastUpdated" : "2019-11-01T09:29:23.356+11:00"
  },
  "publisher" : "HL7 (FHIR Project)",
  "content" : "complete",
  "property" : null,
  "name" : "ResearchStudyPhase",
  "experimental" : false,
  "resourceType" : "CodeSystem",
  "title" : "ResearchStudyPhase",
  "extension" : [ {
    "valueCode" : "brr",
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"
  }, {
    "valueCode" : "draft",
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status"
  }, {
    "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
    "valueInteger" : 1
  }, {
    "extension" : [ {
      "valueString" : "concept",
      "url" : "path"
    }, {
      "url" : "count",
      "valueInteger" : 8
    } ],
    "url" : "http://health-samurai.io/extensions/excised-data"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "draft",
  "id" : "6d3e1690-1a9e-4ce3-a2cd-08d4e37be0c6",
  "valueSet" : "http://hl7.org/fhir/ValueSet/research-study-phase",
  "url" : "http://terminology.hl7.org/CodeSystem/research-study-phase",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.4.642.4.1247"
  } ],
  "caseSensitive" : true,
  "version" : "4.0.1",
  "contact" : [ {
    "telecom" : [ {
      "system" : "url",
      "value" : "http://hl7.org/fhir"
    }, {
      "system" : "email",
      "value" : "fhir@lists.hl7.org"
    } ]
  } ],
  "text" : {
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n            <h2>ResearchStudyPhase</h2>\n            <div>\n              <p>Codes for the stage in the progression of a therapy from initial experimental use in humans in clinical trials to post-market evaluation.</p>\n\n            </div>\n            <p>This code system http://terminology.hl7.org/CodeSystem/research-study-phase defines the following codes:</p>\n            <table class=\"codes\">\n              <tr>\n                <td style=\"white-space:nowrap\">\n                  <b>Code</b>\n                </td>\n                <td>\n                  <b>Display</b>\n                </td>\n                <td>\n                  <b>Definition</b>\n                </td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">n-a\n                  <a name=\"research-study-phase-n-a\"> </a>\n                </td>\n                <td>N/A</td>\n                <td>Trials without phases (for example, studies of devices or behavioral interventions).</td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">early-phase-1\n                  <a name=\"research-study-phase-early-phase-1\"> </a>\n                </td>\n                <td>Early Phase 1</td>\n                <td>Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0.</td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">phase-1\n                  <a name=\"research-study-phase-phase-1\"> </a>\n                </td>\n                <td>Phase 1</td>\n                <td>Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.</td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">phase-1-phase-2\n                  <a name=\"research-study-phase-phase-1-phase-2\"> </a>\n                </td>\n                <td>Phase 1/Phase 2</td>\n                <td>Trials that are a combination of phases 1 and 2.</td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">phase-2\n                  <a name=\"research-study-phase-phase-2\"> </a>\n                </td>\n                <td>Phase 2</td>\n                <td>Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.</td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">phase-2-phase-3\n                  <a name=\"research-study-phase-phase-2-phase-3\"> </a>\n                </td>\n                <td>Phase 2/Phase 3</td>\n                <td>Trials that are a combination of phases 2 and 3.</td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">phase-3\n                  <a name=\"research-study-phase-phase-3\"> </a>\n                </td>\n                <td>Phase 3</td>\n                <td>Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.</td>\n              </tr>\n              <tr>\n                <td style=\"white-space:nowrap\">phase-4\n                  <a name=\"research-study-phase-phase-4\"> </a>\n                </td>\n                <td>Phase 4</td>\n                <td>Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.</td>\n              </tr>\n            </table>\n          </div>",
    "status" : "generated"
  }
}